EconomyHeineken warns weight-loss drug boom could reduce beer sales in British pubs
Heineken told UK hospitality customers that GLP-1 drugs such as Wegovy and Ozempic may curb users’ desire for alcohol, potentially reducing beer and cider sales. It advised pubs to promote half-pints, low- or no-alcohol drinks and food pairings, and said it would keep monitoring changing consumer habits.
Heineken warns weight-loss drug boom could reduce beer sales in British pubs
Economy